Back to search

Democritus University of Thrace (DUTH)

Μελέτη γενετικών παραγόντων στην εμφάνιση νεφροπάθειας σε ασθενείς με σακχαρώδη διαβήτη τύπου 2

Abstract

dc:description

Diabetes mellitus (DM) and especially DM type 2 consists a global pandemic with its incidence and prevalence continuously rising. Major issues of DM2 include morbidity, mortality, cost and complications of D2, with Diabetic Nephropathy (DN) being one of the most important ones. Addressing them requires knowledge of the causes that lead to DM2 complications and environmental and genetic factors are the most prominent.DM2 leads to DN through a variety of mechanisms and pathways. The complexity of DN and the conflicting results in bibliography call for further investigation regarding the pathways and the genes involved in DN manifestation in DM2 patients. An important pathogenetic mechanism of DN appearance in type 2 diabetics is the oxidative stress (OS) pathway, which through inflammation and fibrosis leads to DN.Numerous studies attempt to identify the genes associated with the pathogenesis of DM2 and especially that of OS leading to DN. Many polymorphisms in different populations have been associated with DN, but no genome wide association study has been conducted in the Greek population. The purpose of our study was to identify those genes and polymorphisms that could be related to the occurrence of diabetic nephropathy in type 2 diabetics. In 101 diabetic patients with DN and 229 type 2 diabetics without DN, we studied the effect of genetic polymorphisms on the oxidative stress pathway. Specifically, the studied polymorphisms were found in the genes: ANGPTL7, GPX7, DHCR24, CSDE1, PRDX6, NCF2, GLRX2, TPO, MPV17, GGCX, TTN, SGO2, AOX1, STK25, OXSR1, GPX1, GPR156, RNF7, ADIPOQ, SOD3, SPP1, NFKB1,SEPP1, GPX8, NME5, GPX3, ATOX1, DUSP1, GPX6, GPX5, TNF, AGER, VEGFA, GSTA7P, GSTA2, GSTA1, GSTA5, GSTA3, GSTA4, IPCEF1, SOD2, NUDT1, IL6, GTF2I, NCF1, CALU, NOS3, MSRA, EPHX2, CLU, SCARA3, OXR1, MBL2, SFTPD, PDLIM1, BNIP3, CAT, PRG3, PRDX5, RELA, CCS, MTL5, FOXM1, MGP, KRT1, GPX2, DUOX2, DUOXA1, DUOX1, NOX5, VKORC1, MT3, CYBA, ALOX12, CCL2, CCL5, EPX, MKS1, LPO, MPO, CYGB, GPX4, PRDX2, SIRT2, APOE, PNKP, SRXN1, PRNP, GSS, SGK2, PREX1, SOD1, TXNRD2 και DGKK.22 genes were correlated with a statistical important significance of p<0.05 and in ascending chromosome order were: in chromosome (chr.) 2 the gene of thyroid peroxidase (TPO), Titin gene (TTN), Shugoshin 2 gene (SGO2) and Aldehyde Oxidase 1 gene (AOX1), in chr. 4 Secreted Phosphoprotein 1 gene (SPP1), in chr. 5 Glutathione Peroxidase 3 gene (GPX3), in chr. 6 Interaction Protein for Cytohesin Exchange Factors 1 gene (IPCEF1), Soluble glutathione serine transferase alpha genes -GSTA- Α2, Α1, Α5, Α3, Α4 and pseudogene 7Ρ (GSTA2, GSTA1, GSTA5, GSTA3, GSTA4 and GSTA7P) and Glutathione Peroxidase 6 (GPX6), in chr. 7 Nitric Oxidase Synthase 3 gene (NOS3), in chr. 8 Epoxide Hydroxylase 2 gene (EPHX2), clusterin gene (CLU) and Oxidation Resistance 1 gene (OXR1), in chr. 10 PDLIM domain 1 gene (PDLIM1), in chr. 11 Copper Chaperone for Superoxide Dismutase gene (CCS) and Tesmin gene or Metallothionein-Like Protein 5 gene (MTL5), in chr. 16 Vitamin K Epoxide Reductase Complex Subunit 1 gene (VKORC1), in chr. 17 Eosinophil Peroxidase gene (EPX), in chr.17 Arachidonate 12-Lipoxygenase gene (ALOX12), in chr. 19 Glutathione Peroxidase 4 gene (GPX4), in chr. 20 Prion Protein gene (PRNP) and in chr. 22 Thioredoxin Reductase 2 gene (TXNRD2). In order of ascending statistical significance the polymorphisms possibly correlated with DN in diabetics type 2 were: rs7685225-SPP1 (p=0.001, possible protective role from DN appearance), rs6588678-TPO (p=0.002, possibly contributing to DN), rs56307213-TTN (p=0.002, possibly contributing to DN), rs72648987-TTN (p=0.002, possibly contributing to DN), rs9678469-TPO (p=0.002, possibly contributing to DN), rs72650006-TTN (p=0.005, possibly contributing to DN), rs17532665-SGO2 (p=0.005, possibly contributing to DN), rs7830-NOS3 (p=0.005, possibly contributing to DN), rs45458497-PDLIM1 (p=0.005, possibly contributing to DN), rs17448235-SGO2 (p=0.010, possibly contributing to DN), rs11780592-CLU (p=0.013, possibly contributing to DN), rs1567919-TPO and rs13431646-TPO (p=0.018 και p=0.013 respectively, possible protective role from DN appearance), rs72677233-TTN and rs72646855-TTN (both with a p-value of 0.019, possibly contributing to DN), rs486584-CCS (p=0.019, possible protective role from DN appearance), rs201633492-GPX4 (p=0.019, possibly contributing to DN), rs201971987-TXNRD2 (p=0.019, possibly contributing to DN) and rs737866-TXNRD2 (p=0.02, possibly contributing to DN), rs2725236-SPP1 (p=0.026, possible protective role from DN appearance), rs6732480-TPO (p=0.028, possibly contributing to DN), rs2741335-EPHX2 (p=0.031, possibly contributing to DN), rs3019593-MTL5 (p=0.033, possibly contributing to DN), rs2048727-TPO (p=0.035, possibly contributing to DN), rs9904720-EPX (p=0.035, possibly contributing to DN), rs2230303-GPX3 (p=0.036, possibly contributing to DN), rs6833161-SPP1 (p=0.037, possible protective role from DN appearance), rs8177413-GPX3 (p=0.037, possibly contributing to DN), rs7824574-CLU (p=0.039, possible protective role from DN appearance), rs12106549-TXNRD2 (p=0.039, possibly contributing to DN), rs14309-ALOX12 (p=0.04, possible protective role from DN appearance), rs1293928-IPCEF1 (p=0.041, possible protective role from DN appearance), rs6905523-GSTA7P (p=0.041, possibly contributing to DN), rs10087808-OXR1 (p=0.042, possible protective role from DN appearance), rs35062161-GPX6 (p=0.044, possibly contributing to DN), rs10109171-OXR1 (p=0.044, possibly contributing to DN), rs2465661-AOX1 (p=0.046, possible protective role from DN appearance), rs75586809-VKORC1 (p=0.047, possibly contributing to DN), rs6947821-NOS3 (p=0.048, possible protective role from DN appearance), rs10108813-OXR1 (p=0.048, possible protective role from DN appearance), rs72944451-GSTA4 (p=0.049, possibly contributing to DN), rs1503573-OXR1 (p=0.049, possible protective role from DN appearance), rs11652709-EPX (p=0.049, possibly contributing to DN) and rs6052780-PRNP (p=0.049, possible protective role from DN appearance).In conclusion, in the literature genome wide association studies still remain inconclusive, making it particularly difficult to find a common genetic basis for DN in type 2 diabetic patients. A combination of genetic, environmental factors, and cellular changes, may promote those pathophysiologic mechanisms that lead to renal impairment in DM2. Our study revealed genomic polymorphisms that may either contribute to the appearance of DN or prevent from DN manifestation in Greek type 2 diabetic patients who suffered from DM2 for more than 10 years.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Roumeliotis, Athanasios
  • Ρουμελιώτης, Αθανάσιος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45823

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Roumeliotis, Athanasios; Ρουμελιώτης, Αθανάσιος. Μελέτη γενετικών παραγόντων στην εμφάνιση νεφροπάθειας σε ασθενείς με σακχαρώδη διαβήτη τύπου 2. Democritus University of Thrace (DUTH), 2019. http://hdl.handle.net/10442/hedi/45823